These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Parenteral absorption of insulin from the lung in diabetic children. Elliott RB; Edgar BW; Pilcher CC; Quested C; McMaster J Aust Paediatr J; 1987 Oct; 23(5):293-7. PubMed ID: 3326575 [TBL] [Abstract][Full Text] [Related]
6. Comparisons between inhaled fine particle fractions and lung dose for nebulized aerosols. Finlay WH; Stapleton KW; Zuberbuhler P J Aerosol Med; 1998; 11 Suppl 1():S65-72. PubMed ID: 10180735 [No Abstract] [Full Text] [Related]
7. Inhaled insulin: gone with the wind? Mathieu C; Gale EA Diabetologia; 2008 Jan; 51(1):1-5. PubMed ID: 18026925 [No Abstract] [Full Text] [Related]
8. Insulin-micro- and nanoparticles for pulmonary delivery. Klingler C; Müller BW; Steckel H Int J Pharm; 2009 Jul; 377(1-2):173-9. PubMed ID: 19446621 [TBL] [Abstract][Full Text] [Related]
9. Can in vitro particle size measurements be used to predict pulmonary deposition of aerosol from inhalers? Thiel CG J Aerosol Med; 1998; 11 Suppl 1():S43-52. PubMed ID: 10180732 [No Abstract] [Full Text] [Related]
10. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination. Laube BL Respir Care; 2005 Sep; 50(9):1161-76. PubMed ID: 16122400 [TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of inhaled insulin. Mastrandrea LD; Quattrin T Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1061-75. PubMed ID: 17070613 [TBL] [Abstract][Full Text] [Related]
12. Medical advances. For many diabetics, development of oral insulin--whether via an inhaler or a capsule--could mean the end of daily needlesticks and the beginning of a simpler treatment regimen. Becker C Mod Healthc; 2003 Sep; 33(36):32-4. PubMed ID: 14520835 [No Abstract] [Full Text] [Related]
13. Pulmonary delivery of insulin by liposomal carriers. Huang YY; Wang CH J Control Release; 2006 Jun; 113(1):9-14. PubMed ID: 16730838 [TBL] [Abstract][Full Text] [Related]
14. How well do in vitro particle size measurements predict drug delivery in vivo? Newman SP J Aerosol Med; 1998; 11 Suppl 1():S97-104. PubMed ID: 10180741 [No Abstract] [Full Text] [Related]
15. Use of an impinging jet for dispersion of dry powder inhalation aerosols. Wang Z; Lange CF; Finlay WH Int J Pharm; 2004 May; 275(1-2):123-31. PubMed ID: 15081143 [TBL] [Abstract][Full Text] [Related]
16. Aerosol drug delivery: developments in device design and clinical use. Rottier B; Grasmeijer F; Hagedoorn P; de Boer AH Lancet; 2011 Sep; 378(9795):981-2; author reply 982. PubMed ID: 21907858 [No Abstract] [Full Text] [Related]
17. An efficient computational fluid-particle dynamics method to predict deposition in a simplified approximation of the deep lung. Koullapis PG; Hofemeier P; Sznitman J; Kassinos SC Eur J Pharm Sci; 2018 Feb; 113():132-144. PubMed ID: 28917963 [TBL] [Abstract][Full Text] [Related]
18. The role of particle properties in pharmaceutical powder inhalation formulations. Chew NY; Chan HK J Aerosol Med; 2002; 15(3):325-30. PubMed ID: 12396421 [TBL] [Abstract][Full Text] [Related]
19. A methodology to study impactor particle reentrainment and a proposed stage coating for the NGI. Rissler J; Asking L; Dreyer JK J Aerosol Med Pulm Drug Deliv; 2009 Dec; 22(4):309-16. PubMed ID: 19415989 [TBL] [Abstract][Full Text] [Related]
20. New liquid aerosol generation devices: systems that force pressurized liquids through nozzles. Geller DE Respir Care; 2002 Dec; 47(12):1392-404; discussion 1404-5. PubMed ID: 12467498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]